TET2 mutations are frequent driver mutations in myeloid malignancies, but rather uncommon in CRC, in the latter also exclusively in hypermutated tumors (Muzny et al. 2012b; Ferrone et al. 2020). This evidence concerns the gene TET2 and colorectal carcinoma.